These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33119062)

  • 1. PTPN11 Mutations in the Ras-MAPK Signaling Pathway Affect Human White Matter Microstructure.
    Fattah M; Raman MM; Reiss AL; Green T
    Cereb Cortex; 2021 Feb; 31(3):1489-1499. PubMed ID: 33119062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPN11 Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention.
    Johnson EM; Ishak AD; Naylor PE; Stevenson DA; Reiss AL; Green T
    Cereb Cortex; 2019 Jul; 29(7):2915-2923. PubMed ID: 30059958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
    Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
    Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
    Li XR; Ren YD; Cao B; Huang XL
    Neurosci Lett; 2018 May; 675():127-132. PubMed ID: 29199095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on the Pathogenesis of Cognitive and Neurofunctional Impairments in Patients with Noonan Syndrome: The Role of Rat Sarcoma-Mitogen Activated Protein Kinase Signaling Pathway Gene Disturbances.
    Braun-Walicka N; Pluta A; Wolak T; Maj E; Maryniak A; Gos M; Abramowicz A; Landowska A; Obersztyn E; Bal J
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
    Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
    Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in White Matter Microstructure Among Children With Developmental Coordination Disorder.
    Brown-Lum M; Izadi-Najafabadi S; Oberlander TF; Rauscher A; Zwicker JG
    JAMA Netw Open; 2020 Mar; 3(3):e201184. PubMed ID: 32186744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deviant white matter structure in adults with attention-deficit/hyperactivity disorder points to aberrant myelination and affects neuropsychological performance.
    Onnink AM; Zwiers MP; Hoogman M; Mostert JC; Dammers J; Kan CC; Vasquez AA; Schene AH; Buitelaar J; Franke B
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():14-22. PubMed ID: 25956761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pathogenic variants of the Ras-mitogen-activated protein kinase pathway on major white matter tracts in the human brain.
    Siqueiros-Sanchez M; Dai E; McGhee CA; McNab JA; Raman MM; Green T
    Brain Commun; 2024; 6(4):fcae274. PubMed ID: 39210910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
    Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
    Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White Matter Diffusion of Major Fiber Tracts Implicated in Autism Spectrum Disorder.
    Libero LE; Burge WK; Deshpande HD; Pestilli F; Kana RK
    Brain Connect; 2016 Nov; 6(9):691-699. PubMed ID: 27555361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities.
    Rai B; Naylor PE; Siqueiros-Sanchez M; Wintermark M; Raman MM; Jo B; Reiss AL; Green T
    Transl Psychiatry; 2023 Jul; 13(1):245. PubMed ID: 37407569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11).
    Qiu W; Wang X; Romanov V; Hutchinson A; Lin A; Ruzanov M; Battaile KP; Pai EF; Neel BG; Chirgadze NY
    BMC Struct Biol; 2014 Mar; 14():10. PubMed ID: 24628801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noonan syndrome patients beyond the obvious phenotype: A potential unfavorable metabolic profile.
    Noronha RM; Villares SMF; Torres N; Quedas EPS; Homma TK; Albuquerque EVA; Moraes MB; Funari MFA; Bertola DR; Jorge AAL; Malaquias AC
    Am J Med Genet A; 2021 Mar; 185(3):774-780. PubMed ID: 33382187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lymphoblastic leukemia developing in a patient with Noonan syndrome harboring a PTPN11 germline mutation.
    Sakamoto K; Imamura T; Asai D; Goto-Kawashima S; Yoshida H; Fujiki A; Furutani A; Ishida H; Aoki Y; Hosoi H
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e136-9. PubMed ID: 24072241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series.
    Pugliese A; Della Marina A; de Paula Estephan E; Zanoteli E; Roos A; Schara-Schmidt U; Hentschel A; Azuma Y; Töpf A; Thompson R; Polavarapu K; Lochmüller H
    J Neurol; 2024 Mar; 271(3):1331-1341. PubMed ID: 37923938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.